aluates Reports

$ 0.0

Automative

Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-14J12249

Global Typhoid Vi Polysaccharide Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2024

Code: QYRE-Auto-14J12249

Report

January 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Emergent Biosolutions

Typhoid Vi Polysaccharide Vaccine Market Size

The global Typhoid Vi Polysaccharide Vaccine market was valued at US$ 524 million in 2023 and is anticipated to reach US$ 741.3 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.

Typhoid Vi Polysaccharide Vaccine Market

Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Typhoid Vi Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vi Polysaccharide Vaccine.

Report Scope

The Typhoid Vi Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Vi Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Typhoid Vi Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Typhoid Vi Polysaccharide Vaccine Market Report

Report Metric	Details
Report Name	Typhoid Vi Polysaccharide Vaccine Market
Accounted market size in 2023	US$ 524 million
Forecasted market size in 2030	US$ 741.3 million
CAGR	5.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Child Adult
Segment by Application	Government Institution Private Sector Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi Pasteur SA, GSK, Emergent BioSolutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Typhoid Vi Polysaccharide Vaccine Market growing?

Ans: The Typhoid Vi Polysaccharide Vaccine Market witnessing a CAGR of 5.1% during the forecast period 2024-2030.

What is the Typhoid Vi Polysaccharide Vaccine Market size in 2030?

Ans: The Typhoid Vi Polysaccharide Vaccine Market size in 2030 will be US$ 741.3 million.

Who are the main players in the Typhoid Vi Polysaccharide Vaccine Market report?

Ans: The main players in the Typhoid Vi Polysaccharide Vaccine Market are Sanofi Pasteur SA, GSK, Emergent BioSolutions

What are the Application segmentation covered in the Typhoid Vi Polysaccharide Vaccine Market report?

Ans: The Applications covered in the Typhoid Vi Polysaccharide Vaccine Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Typhoid Vi Polysaccharide Vaccine Market report?

Ans: The Types covered in the Typhoid Vi Polysaccharide Vaccine Market report are Child, Adult

1 Typhoid Vi Polysaccharide Vaccine Market Overview

1.1 Product Overview and Scope of Typhoid Vi Polysaccharide Vaccine

1.2 Typhoid Vi Polysaccharide Vaccine Segment by Type

1.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Child

1.2.3 Adult

1.3 Typhoid Vi Polysaccharide Vaccine Segment by Application

1.3.1 Global Typhoid Vi Polysaccharide Vaccine Market Value by Application: (2024-2030)

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Other

1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts

1.4.1 Global Typhoid Vi Polysaccharide Vaccine Revenue 2019-2030

1.4.2 Global Typhoid Vi Polysaccharide Vaccine Sales 2019-2030

1.4.3 Global Typhoid Vi Polysaccharide Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Typhoid Vi Polysaccharide Vaccine Market Competition by Manufacturers

2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Typhoid Vi Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Typhoid Vi Polysaccharide Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Product Type & Application

2.7 Typhoid Vi Polysaccharide Vaccine Market Competitive Situation and Trends

2.7.1 Typhoid Vi Polysaccharide Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue

2.7.3 Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario by Region

3.1 Global Typhoid Vi Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2019-2030

3.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2019-2024

3.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2025-2030

3.3 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2019-2030

3.3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2019-2024

3.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2025-2030

3.4 North America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country

3.4.1 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)

3.4.3 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)

3.4.4 the United States

3.4.5 Canada

3.5 Europe Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country

3.5.1 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)

3.5.3 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country

3.7.1 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2030)

4.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024)

4.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2025-2030)

4.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2030)

4.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2024)

4.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2025-2030)

4.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2030)

5.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024)

5.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2025-2030)

5.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2030)

5.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2024)

5.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2025-2030)

5.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi Pasteur SA

6.1.1 Sanofi Pasteur SA Corporation Information

6.1.2 Sanofi Pasteur SA Description and Business Overview

6.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio

6.1.5 Sanofi Pasteur SA Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Emergent BioSolutions

6.3.1 Emergent BioSolutions Corporation Information

6.3.2 Emergent BioSolutions Description and Business Overview

6.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio

6.3.5 Emergent BioSolutions Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Typhoid Vi Polysaccharide Vaccine Industry Chain Analysis

7.2 Typhoid Vi Polysaccharide Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Typhoid Vi Polysaccharide Vaccine Production Mode & Process

7.4 Typhoid Vi Polysaccharide Vaccine Sales and Marketing

7.4.1 Typhoid Vi Polysaccharide Vaccine Sales Channels

7.4.2 Typhoid Vi Polysaccharide Vaccine Distributors

7.5 Typhoid Vi Polysaccharide Vaccine Customers

8 Typhoid Vi Polysaccharide Vaccine Market Dynamics

8.1 Typhoid Vi Polysaccharide Vaccine Industry Trends

8.2 Typhoid Vi Polysaccharide Vaccine Market Drivers

8.3 Typhoid Vi Polysaccharide Vaccine Market Challenges

8.4 Typhoid Vi Polysaccharide Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur SA.

GSK

Emergent Biosolutions

List of Tables

Table 1. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Typhoid Vi Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Typhoid Vi Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Typhoid Vi Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Typhoid Vi Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2019-2024)

Table 59. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2025-2030)

Table 60. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Typhoid Vi Polysaccharide Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Typhoid Vi Polysaccharide Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2019-2024)

Table 69. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2025-2030)

Table 70. Sanofi Pasteur SA Corporation Information

Table 71. Sanofi Pasteur SA Description and Business Overview

Table 72. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product

Table 74. Sanofi Pasteur SA Recent Developments/Updates

Table 75. GSK Corporation Information

Table 76. GSK Description and Business Overview

Table 77. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. GSK Typhoid Vi Polysaccharide Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Emergent BioSolutions Corporation Information

Table 81. Emergent BioSolutions Description and Business Overview

Table 82. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product

Table 84. Emergent BioSolutions Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Typhoid Vi Polysaccharide Vaccine Distributors List

Table 88. Typhoid Vi Polysaccharide Vaccine Customers List

Table 89. Typhoid Vi Polysaccharide Vaccine Market Trends

Table 90. Typhoid Vi Polysaccharide Vaccine Market Drivers

Table 91. Typhoid Vi Polysaccharide Vaccine Market Challenges

Table 92. Typhoid Vi Polysaccharide Vaccine Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Typhoid Vi Polysaccharide Vaccine

Figure 2. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Typhoid Vi Polysaccharide Vaccine Market Share by Type in 2023 & 2030

Figure 4. Child Product Picture

Figure 5. Adult Product Picture

Figure 6. Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Typhoid Vi Polysaccharide Vaccine Market Share by Application in 2023 & 2030

Figure 8. Government Institution

Figure 9. Private Sector

Figure 10. Other

Figure 11. Global Typhoid Vi Polysaccharide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Typhoid Vi Polysaccharide Vaccine Market Size (2019-2030) & (US$ Million)

Figure 13. Global Typhoid Vi Polysaccharide Vaccine Sales (2019-2030) & (K Units)

Figure 14. Global Typhoid Vi Polysaccharide Vaccine Average Price (USD/Unit) & (2019-2030)

Figure 15. Typhoid Vi Polysaccharide Vaccine Report Years Considered

Figure 16. Typhoid Vi Polysaccharide Vaccine Sales Share by Manufacturers in 2023

Figure 17. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Typhoid Vi Polysaccharide Vaccine Players: Market Share by Revenue in 2023

Figure 19. Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Typhoid Vi Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2030)

Figure 22. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)

Figure 23. the United States Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2030)

Figure 26. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)

Figure 27. Germany Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. UK Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2019-2030)

Figure 34. China Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2030)

Figure 44. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Typhoid Vi Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Typhoid Vi Polysaccharide Vaccine by Type (2019-2030)

Figure 54. Global Revenue Market Share of Typhoid Vi Polysaccharide Vaccine by Type (2019-2030)

Figure 55. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Typhoid Vi Polysaccharide Vaccine by Application (2019-2030)

Figure 57. Global Revenue Market Share of Typhoid Vi Polysaccharide Vaccine by Application (2019-2030)

Figure 58. Global Typhoid Vi Polysaccharide Vaccine Price (USD/Unit) by Application (2019-2030)

Figure 59. Typhoid Vi Polysaccharide Vaccine Value Chain

Figure 60. Typhoid Vi Polysaccharide Vaccine Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions